PEAK6 Group’s West Pharmaceutical WST Stock Holding History

PEAK6 Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-343	Closed	-$29K	–	5086
2016 Q4	$29K	Buy	+343	New	+$27K	﹤0.01%	4363
2014 Q1	–	Sell	-200	Closed	-$10K	–	5458
2013 Q4	$10K	Buy	+200	New	+$9.36K	﹤0.01%	4699

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

PEAK6 Group's WST Position: Q1 2017 in Review

PEAK6 Group sold out of West Pharmaceutical (WST) in Q1 2017, closing a stake of 343 shares — an estimated $29K sold.

PEAK6 Group first reported a position in WST in Q4 2013 and held it in 2 quarters. The position peaked at $29K in Q4 2016. 295 funds tracked by Wall St. Rank hold WST as of Q1 2017.

PEAK6 Group reported no remaining West Pharmaceutical position as of Q1 2017 after selling out during the quarter.
PEAK6 Group sold 343 West Pharmaceutical shares in Q1 2017, an estimated $29K.
PEAK6 Group first reported a position in West Pharmaceutical in Q4 2013 and held it in 2 quarters.
PEAK6 Group's West Pharmaceutical position peaked at $29K in Q4 2016.
295 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2017.

Based on PEAK6 Group's 13F filing for Q1 2017, filed 15 May 2017.